The Trump administration is easing restrictions on psychedelic therapies, but the FDA’s slow approval system still stifles innovation.

The federal Food and Drug Administration nannies have been tormenting Americans for decades, which is no surprise given the pitfalls of putting bureaucrats in charge of such an important function as …